Qiagen N.v. · NYSE:QGEN
Qiagen — Investor Presentation (December 2024)
14 slides from Qiagen's investor presentation, Dec 16, 2024
Slide 1: Deep Dive – QDI
Deep Dive QIAGEN DIGITAL INSIGHTS POWERFUL ANALYTICS TO UNDERSTAND GENOMICS Deep Dive – QDI December 16, 2024 1
Slide 2: Biologic Data Exploded in the Past Decade
Bioinformatics QDI intro QDI growth BIOLOGIC DATA EXPLODED IN THE PAST DECADE The multi-omics revolution Higher throughput and lower cost sequencing lead to Samples Genomic data ~2 – 40 Exabytes(1) Increasing amounts per year of multi-omics data Addressing these challenges is key to improving our li
Slide 3: Bioinformatics Market Growing and Value-Adding
Bioinformatics QDI intro QDI growth BIOINFORMATICS MARKET GROWING AND VALUE-ADDING >10% Vast genomic data processing CER CAGR Lower cost genomic testing fueling growth Faster, better insights ~1/3 time saving via AI-genomic analysis(1) ~$1.0 bn Shorter pharma drug discovery timeline >30% with high R
Slide 4: QIAGEN Digital Insights (QDI) Integrated
Bioinformatics QDI intro QDI growth Delivering QDI software solutions for NGS workflow QIAGEN DIGITAL Sample Library NGS Bio- INSIGHTS (QDI) prep prep analysis informatics INTEGRATED INTO WORKFLOWS QIAGEN QIAGEN QIAGEN NGS Digital kits kits partners Insights Software insights drive next actions NGS
Slide 5: #1 in Bioinformatics Serves Broad Customer Base
Bioinformatics QDI intro QDI growth #1 IN BIOINFORMATICS SERVES BROAD CUSTOMER BASE Our holistic portfolio Our customers Our goals Current QDI sales DATA SCIENCE Discovery ≥$200 mn e.g., research in pharma, ~60% net sales CER biotech, academia DATA target (2028) Scientist-curated TOOLS and validated
Slide 6: Our Gold-Standard Data Differentiates QDI
Bioinformatics QDI intro QDI growth OUR GOLD-STANDARD DATA DIFFERENTIATES QDI Our DATA – Our superpower 643 mn Comprehensive Biomedical relationships Multi-omics data across 40 knowledge bases Powered by 150+ scientists 6.4 mn+ +125% accuracy vs AI-only Gene causal relationships 26 mn+ QDI AI-ready
Slide 7: We Deliver Tools from Sample to Insight
Bioinformatics QDI intro QDI growth WE DELIVER TOOLS FROM SAMPLE TO INSIGHT Discovery TOOLS Understand Analyze Compare Contextualize disease biology Biological pathways Patterns and Insights to biological and enable new and molecular variations across systems and clinical therapeutics interactions d
Slide 8: Tools Discovery Use Case
Bioinformatics QDI intro QDI growth See all tissues impacted Understand all biological pathways and processes that lead to the condition TOOLS DISCOVERY USE CASE DRUG TARGET IDENTIFICATION Understand all places to measure or interact and prevent damage 8
Slide 9: Tools Clinical Use Case
Bioinformatics QDI intro QDI growth TOOLS CLINICAL USE CASE Proposed therapy ACTIONABLE, PATIENT-SPECIFIC REPORT Supporting evidence Identified variant 9
Slide 10: Customer Testimonial: QDI Clinical Tools in Action
Bioinformatics QDI intro QDI growth STEVE CHAPMAN CUSTOMER TESTIMONIAL CHIEF EXECUTIVE QDI CLINICAL TOOLS OFFICER IN ACTION 10
Slide 11: Data Science for AI-Drug Discovery
Bioinformatics QDI intro QDI growth Challenge How QDI helps High-quality data need Comprehensive to train advanced knowledge base AI models for drug discovery for training Machine Learning DATA SCIENCE models and Large Language FOR AI-DRUG Models DISCOVERY TOOL TRAINING AND MINING Complex data analy
Slide 12: Focus on SaaS and AI to Expand Market Leadership
Bioinformatics QDI intro QDI growth FOCUS ON SAAS AND AI TO EXPAND MARKET LEADERSHIP 2028 goals Coming in 2025 Deepen global commercial reach and +40% 3 new AI product SaaS transition for sustainable growth SaaS sales specialists enhancements >14 10+ new DATA Invest in new AI technologies AI-enabled
Slide 13: Continuously Building on Our Attractive Business Model
Bioinformatics QDI intro QDI growth CONTINUOUSLY BUILDING ON OUR ATTRACTIVE BUSINESS MODEL >$110 mn QDI net sales CER target (2024) Solutions Internal development across and acquisitions Accounts in >4,000 60+ countries customers for 30+ years Largest user >90,000 base in the market Unique profitabi
Slide 14: Your contacts
Your contacts Dr. Domenica Martorana Associate Director Calendar Global Investor Relations Q4 and FY 2024 results February 2025 Phone: +49 2103 29 11244 E-mail: domenica.martorana@qiagen.com Q1 2025 results May 2025 Alexandra Koenig Coordinator Share information Investor Relations NYSE: QGEN Phone: